CaroGen

Last updated: December 20, 2023

Bijan Almassian - Co-Founder, Chairman and CEO
Bijan Almassian - Co-Founder, Chairman and CEO
Country: USA | Funding: $11.4M (+)

Website: http://www.carogencorp.com/

CaroGen Corporation is an immunotherapy company employing a virus-like vesicle (VLV) platform technology. CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.